Key facts
- Notable investors include Xi'an Jingfa Asset Management.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for LiangSheng Biotek
- ·The full record, as it builds
Funding rounds
No funding rounds for LiangSheng Biotek are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About LiangSheng Biotek
Manufacturer of diagnostic products intended to advance rapid disease detection and health monitoring. The company offers biochemical assays, immunoassay reagents, and point-of-care testing devices, enabling hospitals, clinics, and individual users to achieve efficient diagnostics and improved healthcare management.
- Sector
- Healthcare
- HQ
- Xi'an, China
- Founded
- 2013
- Employees
- 24
- Website
- liangshengscilife.cn/
- Ownership
- Privately Held (backing)
LiangSheng Biotek doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in LiangSheng Biotek shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on LiangSheng Biotek in its N-PORT filings yet. We sweep new filings monthly.